Skip to main content (Press Enter).
U.S. Air Force Logo
Home
About Us
Units
History
Leadership
Fact Sheets
Media
News
Features
Commentaries
Resources
Airman & Family Readiness
Chaplain
Director of Psychological Health
Employment
Environmental Safety
Freedom of Information Act
ID Card Office
Personal Financial Counselor
Sexual Assault and Response
Contact Us
FAQs
Sexual-Misconduct-Disciplinary-Actions
106th Rescue Wing
Contact Us
DVIDSVideoPlayer
Playlist:
Search Results
Video by Sara Barger
Player Embed Code:
<iframe width='500' height='300' scrolling='no' frameborder='0' style='border: none; overflow: hidden; width: 500px; height: 300px;' allowtransparency='true' src='https://www.dvidshub.net/video/embed/893747'></iframe>
Download
Embed
Share
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT (captioned)
Defense Health Agency
Aug. 14, 2023 | 3:47
The Broad-Spectrum Snakebite Antidote IPT and small-business partner, Ophirex Inc, accelerated the technical and programmatic maturity of the critical life-saving drug, varespladib, including two pivotal clinical trials in 4 years. The team mitigated manufacturing and clinical risks through early FDA engagement and capitalized on opportunities to accelerate schedule, utilizing SBIR contracting mechanisms; financial and acquisition planning; and stakeholder engagement. The team’s efforts will result in FDA-approval and fielding nearly 3 years ahead of schedule, providing an important capability for Warfighters deployed in far-forward, austere conditions where snakebites are a significant threat to life and limb.
This version of the video has captions embedded.
More
Tags
Ft. Detrick
MHSRS 2023
Broad-Spectrum Snakebite Antidote
BSSA
More
Up Next
3:49
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT (clean version)
Now Playing
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT (captioned)
3:47
MHSRS Award Winner: Broad-Spectrum Snakebite Antidote IPT
More Videos